Skip to main content
. 2020 Mar 18;3:130. doi: 10.1038/s42003-020-0842-3

Fig. 3. Inflammatory bowel disease patients express CD98.

Fig. 3

The Swiss IBD cohort study provided colonic or ileal biopsies from Crohn’s disease (CD) or ulcerative colitis (UC) patients which were in remission (quiescent) or with active disease. Healthy patients were recruited at the University Hospital Basel. a CD98hc/SLC3A2 and CD98lc/SLC7A5 expression was determined by qRT-PCR. b Cryosections of inflamed and non-inflamed regions of the same CD or UC patient (patient identification numbers in brackets) were stained for CD98hc and counterstained with NucBlue. Immunofluorescence was carried out with biopsies of five healthy patients, and four UC and four CD patients. c CD98hc fluorescence intensity of staining of biopsies from CD and UC patients. In the figures of the panels (a) and (c), the mean is indicated with each dot representing one patient. The data were analyzed by Mann–Whitney U test; *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.